产品详情
所在位置: 首页> 产品目录> 一抗>
  • 产品名称:anti-MAPTantibody(Microtubule-AssociatedProteintau)(AA3-214)

  • 产品型号:
  • 产品厂商:SYSY
  • 产品文档:
你添加了1件商品 查看购物车
简单介绍:
anti-MAPTantibody(Microtubule-AssociatedProteintau)(AA3-214)
详情介绍:
Immunogen Recombinant mouse tau (aa 3-214).
Specificity Specific for tau.
Purification antiserum
Alternative Name tau (MAPT Antibody Abstract)
Pathways MAPK Signaling, Microtubule Dynamics, M Phase, Regulation of Cell Size
Application Notes WB: 1 : 1000 (AP staining)
ICC: 1 : 1000
Comment

The antibody binds phosphorylated and non-phosphorylated tau proteins.

Restrictions For Research Use only
Format Liquid
Buffer PBS
Handling Advice Crude antisera are more robust than monoclonals. With anti-microbials added, they may be stored at 4?°C.
Serum does not contain active proteases, in fact, serum itself contains a powerful cocktail of protease inhibitors. Frozen storage (-20?°C),however, is preferable.
Storage 4 °C/-20 °C
Storage Comment Unlabeled antibodies are stable in this form without loss of quality at ambient temperatures for several weeks or even months. They can be stored at 4 °C for several years.
Supplier Images
Immunocytochemistry (ICC) image for anti-Microtubule-Associated Protein tau (MAPT) (AA 3-214) antibody (ABIN1742568) anti-Microtubule-Associated Protein tau (MAPT) (AA 3-214) antibody
Immunohistochemistry (IHC) image for anti-Microtubule-Associated Protein tau (MAPT) (AA 3-214) antibody (ABIN1742568) anti-Microtubule-Associated Protein tau (MAPT) (AA 3-214) antibody (Image 2)
Western Blotting (WB) image for anti-Microtubule-Associated Protein tau (MAPT) (AA 3-214) antibody (ABIN1742568) dilution: 1 : 1000, sample: mouse brain homogenate
Product cited in: Gauthier-Kemper, Weissmann, Golovyashkina, Seb?-Lemke, Drewes, Gerke, Heinisch, Brandt: "The frontotemporal dementia mutation R406W blocks tau's interaction with the membrane in an annexin A2-dependent manner." in: The Journal of cell biology, Vol. 192, Issue 4, pp. 647-61, 2011 (PubMed).

Abe, Borson, Gambello, Wang, Cavalli: "Mammalian target of rapamycin (mTOR) activation increases axonal growth capacity of injured peripheral nerves." in: The Journal of biological chemistry, Vol. 285, Issue 36, pp. 28034-43, 2010 (PubMed).